ABEO (abeonatherapeutics.com) Earnings per share growth this year

Official company branding of Abeona Therapeutics (ABEO)

The annual earnings per share trend correlates with the efficient express delivery of cell products, which ensures high margins for Abeona Therapeutics (ABEO). A loyal staff of scientists and the recruitment of specialized experts strengthen the R&D core. However, cash flows remain volatile until the commercial launch of the drugs. The current level of -196.70 captures fresh values, helping to assess the balance between potential returns and the startup's risks.

ABEO (Abeona Therapeutics Inc.) Earnings per share growth in current year history from 07/04/2022 to 11/17/2026

Financial and market metric breakdowns for Abeona Therapeutics Inc. (ABEO)

Basic company analysis:abeonatherapeutics.com (ABEO)
Manufactured products of abeonatherapeutics.com

Assessing the investment reliability of assets requires an analysis of a business's ability to generate real income under inflationary pressure. The year-over-year earnings per share trend measures cost management efficiency, which, given the stable capacity utilization of Abeona Therapeutics (ABEO) biopharmaceutical facilities, confirms the company's ability to monetize technological upgrades, reflecting final profitability through the relative annual growth of net income per share.

Main competitors

Earnings per share growth rate in current year Vertex Pharmaceuticals Inc. (VRTX)|ALNY (Alnylam) - Earnings growth in current year|Earnings per share growth this year INSM (Insmed)|Net earnings per share growth this year UTHR (United Therapeutics Corporation)|BMRN (BioMarin Pharmaceutical Inc.) - Earnings per share increase in current year|Earnings per share growth in current year BridgeBio BBIO|Earnings per share increase in current year BGM|Cogent Biosciences - Earnings growth in current year|Earnings per share increase in current year XERS (Xeris Biopharma)|KROS: Earnings growth in current year|Arcturus Therapeutics Inc (ARCT) - Earnings growth in current year|Earnings per share growth in current year Eton Pharma|KMDA: Earnings per share increase in current year|Earnings per share growth in current year fulcrumtx.com (FULC)|Net earnings per share growth this year Mereo BioPharma Group plc MREO|Earnings per share growth in current year Protalix BioTherapeutics PLX|Earnings growth in current year Pliant Therapeutics PLRX|appliedtherapeutics.com - Earnings growth in current year|Earnings per share increase in current year RNTX (Rein Therapeutics, Inc.)|GELS: Earnings growth in current year|Earnings per share growth rate in current year Aytu BioPharma, Inc. (AYTU)|CMMB (Chemomab Therapeutics Ltd) - Earnings growth in current year|Earnings per share growth this year SRXH (SRx Health Solutions)|Net earnings per share growth this year PLRZ (Polyrizon Ltd)|AEZS - Earnings per share growth rate in current year|Earnings per share growth in current year Cyclo Therapeutics Inc. CYTH|Inozyme Pharma, Inc. (INZY) - Earnings per share growth rate in current year|RPHM: Net earnings per share growth this year|Earnings per share growth rate in current year COSCIENS Biopharma Inc